Bongolan, Mychill O.

HRN: 21-49-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/13/2022
07/20/2022
IV
4.5g
Q8
G2P1 (1011); Complete Abortion; UTI
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: